The tumor antigen epcam: Tetraspanins and the tight junction protein claudin-7, new partners, new functions

Frontiers in Bioscience

Volumn 13, Issue 15, 2008, Pages 5847-5865

  Naour, Francois Le ^a,b   Zoller, Margot ^c,d  

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY OF KARLSRUHE   (Germany)

Author keywords

Claudins; EpCAM; Membrane Microdomains; Protein Complexes; Review; Tetraspanins; Tumor Progression

Indexed keywords

CELL ADHESION MOLECULE; CLDN7 PROTEIN, HUMAN; INTEGRIN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; TACSTD1 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR PROTEIN;

CARCINOMA; HUMAN; IMMUNOLOGY; METABOLISM; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; TIGHT JUNCTION;

ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CARCINOMA; CELL ADHESION MOLECULES; HUMANS; INTEGRINS; MEMBRANE PROTEINS; NEOPLASM PROTEINS; NEOPLASMS; TIGHT JUNCTIONS;

EID: 52049125205     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3121     Document Type: Review

References (268)

1. H. G. Gottlinger, I. Funke, J. P. Johnson, J. M. Gokel and G. Riethmüller: The epithelial cell surface antigen 17-1A, a target for antibody-mediated tumor therapy: its biochemical nature, tissue distribution and recognition by different monoclonal antibodies.Int J Cancer 38, 47-53 (1986) (Pubitemid 16056257)
2. H. Peinado, D. Olmeda and A. Cano: Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7, 415-428 (2007) (Pubitemid 46809165)
3. E. Avin, J. Haimovich and N. Hollander: Anti-idiotype x anti-CD44 bispecific antibodies inhibit invasion of lymphoid organs by B cell lymphoma. J Immunol 173, 4736-4743 (2004) (Pubitemid 39280710)
4. P. A. Baeuerle and O. Gires: EpCAM (CD326) finding its role in cancer. Br J Cancer 96, 417-423 (2007) (Pubitemid 46215211)
5. M. Andre, J. P. Le Caer, C. Greco, S. Planchon, W. El Nemer, C. Boucheix, E. Rubinstein, J. Chamot-Rooke and F. Le Naour: Proteomic analysis of the tetraspanin web using LC-ESI-MS/MS and MALDI-FTICR-MS. Proteomics 6, 1437-1449 (2006)
6. D. S. Schmidt, P. Klingbeil, M. Schnölzer and M. Zöller: CD44 variant isoforms associate with tetraspanins and EpCAM. Exp Cell Res 297, 329-347 (2004) (Pubitemid 38798397)
7. M. Ladwein, U. F. Pape, D. S. Schmidt, M. Schnölzer, S. Fiedler, L. Langbein, W. W. Franke, G. Moldenhauer and M. Zöller: The cell-cell adhesion molecule EpCAM interacts directly with the tight junction protein claudin-7. Exp Cell Res 309, 345-357 (2005) (Pubitemid 41317358)
8. F. Le Naour, M. Andre, C. Boucheix and E. Rubinstein: Membrane microdomains and proteomics: lessons from tetraspanin microdomains and comparison with lipid rafts. Proteomics 6, 6447-6454 (2006) (Pubitemid 46048385)
9. M. E. Hemler: Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol 6, 801-811 (2005) (Pubitemid 41726118)
10. C. M. Van Itallie and J. M. Anderson: Claudins and epithelial paracellular transport. Annu Rev Physiol 68, 403-429 (2006)
11. M. Furuse and S. Tsukita: Claudins in occluding junctions of humans and flies. Trends Cell Biol 16, 181-188 (2006)
12. M. Koval: Claudins-key pieces in the tight junction puzzle. Cell Commun Adhes 13, 127-138 (2006) (Pubitemid 44349316)
13. M. Balzar, M. J. Winter, C. J. de Boer, and S. V. Litvinov: The biology of the 17-1A antigen (Ep-CAM). J Mol Med 77, 699-712 (1999)
14. M. J. Winter, I. D. Nagtegaal, J. H. van Krieken and S. V. Litvinov: The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology. Am J Pathol 163, 2139-2148 (2003) (Pubitemid 37466457)
15. A. Armstrong and S. L. Eck: EpCAM: A new therapeutic target for an old cancer antigen. Cancer Biol Ther 2, 320-236 (2003)
16. M. Mack, R. Gruber, S. Schmidt, G. Riethmüller and P. Kufer: Biologic properties of a bispecific single-chain antibody directed against 17-1A (EpCAM) and CD3: tumor cell-dependent T cell stimulation and cytotoxic activity. J Immunol 158, 3965-3970, (1997) (Pubitemid 127488757)
17. J. E. Frodin, J. Fagerberg, A. L. Hjelm-Skog, M. Liljefors, P. Ragnhammar and H. Mellstedt: MAb17-1A and cytokines for the treatment of patients with colorectal carcinoma. Hybrid Hybridomics 21, 99-101 (2002) (Pubitemid 34756989)
18. H. Mellstedt, J. Fagerberg, J. E. Frodin, A. L. Hjelm-Skog, M. Liljefors, K. Markovic, S. Mosolits and P. Ragnhammar: Ga733/EpCAM as a target for passive and active specific immunotherapy in patients with colorectal carcinoma. Ann NY Acad Sci 910, 254-261 (2000)
19. J. Zaloudik, W. Li, L. Jacob, M. P. Kieny, R. Somasundaram, B. Acres, H. Song, T. Zhang, J. Li and D. Herlyn: Inhibition of tumor growth by recombinant vaccinia virus expressing GA733/CO17-1A/EpCAM/KSA/KS1-4 antigen in mice. Cancer Gene Ther 9, 382-389 (2002) (Pubitemid 34289457)
20. A. J. Linnenbach, J. Wojcierowski, S. A. Wu, J. J. Pyrc, A. H. Ross, B. Dietzschold, D. Speicher and H. Koprowski: Sequence investigation of the major gastrointestinal tumorassociated antigen gene family, GA733. Proc Natl Acad Sci USA 86, 27-31 (1989) (Pubitemid 19036329)
21. J. M. Chong and D. W. Speicher: Determination of disulfide bond assignments and N-glycosylation sites of the human gastrointestinal carcinoma antigen GA733-2 (CO17-1A, EGP, KS1-4, KSA, and Ep-CAM). J Biol Chem 276, 5804-5813 (2001)
22. V. Cirulli, L. Crisa, G. M. Beattie, M. I. Mally, A. D. Lopez, A. Fannon, A. Ptasznik, L. Inverardi, C. Ricordi, T. Deerinck, M. Ellisman, R. A. Reisfeld and A. Hayek: KSA antigen Ep-CAM mediates cell-cell adhesion of pancreatic epithelial cells: morphoregulatory roles in pancreatic islet development. J Cell Biol 140, 1519-1534 (1998) (Pubitemid 28152999)
23. S. V. Litvinov, H. A. Bakker, M. M. Gourevitch, M. P. Velders and S. O. Warnaar: Evidence for a role of the epithelial glycoprotein 40 (Ep-CAM) in epithelial cell-cell adhesion. Cell Adhes Commun 2, 417-428 (1994) (Pubitemid 24351019)
24. S. V. Litvinov, M. P. Velders, H. A. Bakker, G. J. Fleuren and S. O. Warnaar: Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule. J Cell Biol 125, 437-446 (1994) (Pubitemid 24135956)
25. M. Trebak, G. E. Begg, J. M. Chong, E. V. Kanazireva, D. Herlyn and D. W. Speicher: Oligomeric state of the colon carcinoma-associated glycoprotein GA733-2 (Ep-CAM/EGP40) and its role in GA733-mediated homotypic cell-cell adhesion. J Biol Chem 276, 2299-2309 (2001) (Pubitemid 32109716)
26. M. Balzar, I. H. Briaire-de Bruijn, H. A. Rees-Bakker, F. A. Prins, W. Helfrich, L. de Leij, G. Riethmüller, S. Alberti, S. O. Warnaar, G. J. Fleuren and S. V. Litvinov: Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions. Mol Cell Biol 21, 2570-280 (2001)
27. M. P. Schön, M. Schön, C. E. Klein, U. Blume, S. Bisson and C. E. Orfanos: Carcinoma-associated 38-kD membrane glycoprotein MH 99/KS 1/4 is related to proliferation and age of transformed epithelial cell lines. J Invest Dermatol 102, 987-991 (1994)
28. P. M. McLaughlin, M. Trzpis, B. J. Kroesen, W. Helfrich, P. Terpstra, W. H. Dokter, M. H. Ruiters, L. F. de Leij and M. C. Harmsen: Use of the EGP-2/Ep-CAM promoter for targeted expression of heterologous genes in carcinoma derived cell lines. Cancer Gene Ther 11, 603-612 (2004) (Pubitemid 39195410)
29. O. Gires, S. Eskofier, S. Lang, R. Zeidler and M. Munz: Cloning and characterisation of a 1.1 kb fragment of the carcinoma-associated epithelial cell adhesion molecule promoter. Anticancer Res 23, 3255-3261 (2003) (Pubitemid 36975421)
30. J. Behrens: Cell contacts, differentiation, and invasiveness of epithelial cells. Invasion Metastasis 14, 61-70 (1994)
31. M Varga, P. Obrist, S. Schneeberger, G. Muhlmann, C. Felgel-Farnholz, D. Fong, M. Zitt, T. Brunhuber, G. Schafer, G. Gastl and G. Spizzo: Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival. Clin Cancer Res 10, 3131-3136 (2004) (Pubitemid 38619694)
32. G. Gastl, G. Spizzo, P. Obrist, M. Dunser and G. Mikuz: Ep-CAM overexpression in breast cancer as a predictor of survival. Lancet 356, 1981-1982 (2000)
33. S. V. Litvinov, M. Balzar, M. J. Winter, H. A. Bakker, I. H. Briaire-de Bruijn, F. Prins, G. J. Fleuren and S. O. Warnaar: Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins. J Cell Biol 139, 1337-1348 (1997) (Pubitemid 27523219)
34. M. J. Winter, B. Nagelkerken, A. E. Mertens, H. A. Rees-Bakker, I. H. Briaire-de Bruijn and S. V. Litvinov: Expression of Ep-CAM shifts the state of cadherin-mediated adhesions from strong to weak. Exp Cell Res 285, 50-58 (2003) (Pubitemid 36390155)
35. E. Bremer, J. Kuijlen, D. Samplonius, H. Walczak, L. de Leij and L. W. Helfrich: Target cell-restricted and -enhanced apoptosis induction by a scFv:sTRAIL fusion protein with specificity for the pancarcinoma-associated antigen EGP2. Int J Cancer 109, 281-290 (2004) (Pubitemid 38240933)
36. B. Mayer, G. Klement, M. Kaneko, S. Man, S. Jothy, J. Rak and R. S. Kerbel: Multicellular gastric cancer spheroids recapitulate growth pattern and differentiation phenotype of human gastric carcinomas. Gastroenterology 121, 839-852 (2001) (Pubitemid 32962576)
37. A. Trojan, M. Witzens, J. L. Schultze, R. H. Vonderheide, S. Harig, A. M. Krackhardt, R. A. Stahel and J. G. Gribben: Generation of cytotoxic T lymphocytes against native and altered peptides of human leukocyte antigen-A*0201 restricted epitopes from the human epithelial cell adhesion molecule. Cancer Res 61, 4761-4765 (2001) (Pubitemid 32691888)
38. F. J. Lovicu and J. W. McAvoy: FGF-induced lens cell proliferation and differentiation is dependent on MAPK (ERK1/2) signalling. Development 128, 5075-5084 (2001) (Pubitemid 34083034)
39. M. Munz, R. Zeidler and O. Gires: The tumourassociated antigen EpCAM upregulates the fatty acid binding protein E-FABP. Cancer Lett 225, 151-157 (2005) (Pubitemid 40732778)
40. J. C. Guillemot, M. Naspetti, F. Malergue, P. Montcourrier, F. Galland and P. Naquet: Ep-CAM transfection in thymic epithelial cell lines triggers the formation of dynamic actin-rich protrusions involved in the organization of epithelial cell layers. Histochem Cell Biol 116, 371-378 (2001) (Pubitemid 32972331)
41. M. Munz, C. Kieu, B. Mack, B. Schmitt, R. Zeidler and O. Gires: The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Oncogene 23, 5748-5758 (2004) (Pubitemid 39093020)
42. W. A. Osta, Y. Chen, K. Mikhitarian, M. Mitas, M. Salem, Y. A. Hannun, D. J. Cole and W. E. Gillanders: EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res 64, 5818-5824 (2004) (Pubitemid 39095582)
43. S. Hussain, A. Pluckthun, T. M. Allen and U. Zangemeister-Wittke: Chemosensitization of carcinoma cells using epithelial cell adhesion molecule-targeted liposomal antisense against bcl-2/bcl-xL. Mol Cancer Ther 5, 3170-3180 (2006) (Pubitemid 46092060)
44. L. Ricci-Vitiani, D. G. Lombardi, E. Pilozzi, M. Biffoni, M. Todaro, C. Peschle and R. De Maria: Identification and expansion of human colon-cancerinitiating cells. Nature 445, 111-5 (2007) (Pubitemid 46067311)
45. C. A. O'Brien, A. Pollett, S. Gallinger and J. E. Dick: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106-110 (2007) (Pubitemid 46067310)
46. M. Al-Hajj, M. S. Wicha, A. Benito-Hernandez, S. J. Morrison and M. F. Clarke: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100, 3983-3988 (2003) (Pubitemid 36418143)
47. C. Li, D. G. Heidt, P. Dalerba, C. F. Burant, L. Zhang, V. Adsay, M. Wicha, M. F. Clarke and D. M. Simeone: Identification of pancreatic cancer stem cells.Cancer Res 67, 1030-1037 (2007)
48. F. Momburg, G. Moldenhauer, G. J. Hämmerling and P. Möller: Immunohistochemical study of the expression of a Mr 34, 000 human epithelium-specific surface glycoprotein in normal and malignant tissues. Cancer Res 47, 2883-2891 (1987) (Pubitemid 17113431)
49. P. L. Bergsagel, C. Victor-Kobrin, L. A. Brents, J. F. Mushinski and W. M. Kuehl: Genes expressed selectively in plasmacytomas: markers of differentiation and transformation. Curr Top Microbiol Immunol 182, 223-228 (1992) (Pubitemid 23018885)
50. S. Braun, and K. Pantel: Prognostic significance of micrometastatic bone marrow involvement Breast Cancer Res Treat 52, 201-216 (1998) (Pubitemid 29056096)
51. S. V. Litvinov, W. van Driel, C. M. van Rhijn, H. A. Bakker, H. van Krieken, G. J. Fleuren and S. O. Warnaar: Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation. Am J Pathol 148, 865-875 (1996) (Pubitemid 126660678)
52. P. Ruck, G. Wichert, R. Handgretinger and E. Kaiserling: Ep-CAM in malignant liver tumours. J Pathol 191, 102-103 (2000) (Pubitemid 30235656)
53. D. B. Seligson, A. J. Pantuck, X. Liu, Y. Huang, S. Horvath, M. H. Bui, K. R. Han, A. J. Correa, M. Eeva, S. Tze, A. S. Belldegrun and R. A. Figlin: Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma. Clin Cancer Res 10, 2659-2669 (2004) (Pubitemid 38509139)
54. P. T. Went, A. Lugli, S. Meier, M. Bundi, M. Mirlacher, G. Sauter and S. Dirnhofer: Frequent EpCam protein expression in human carcinomas. Hum Pathol 35, 122-128 (2004) (Pubitemid 38133932)
55. S. Basak, D. Speicher, S. Eck, W. Wunner, G. Maul, M. S. Simmons and D. Herlyn: Colorectal carcinoma invasion inhibition by CO17-1A/GA733 antigen and its murine homologue. J Natl Cancer Inst 90, 691-697 (1998) (Pubitemid 28222143)
56. M. Herlyn, Z. Steplewski, D. Herlyn and H. Koprowski: Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. Proc Natl Acad Sci USA 76, 1438-1442 (1979) (Pubitemid 9136880)
57. G. J. Fleuren, A. Gorter, P. J. Kuppen, S. Litvinov and S. O. Warnaar: Tumor heterogeneity and immunotherapy of cancer. Immunol Rev 145, 91-122 (1995)
58. C. J. Piyathilake, A. R. Frost, H. Weiss, U. Manne, D. C. Heimburger and W. E. Grizzle: The expression of Ep-CAM (17-1A) in squamous cell cancers of the lung. Hum Pathol 31, 482-487 (2000) (Pubitemid 30262871)
59. S. Kuhn, M. Koch, T. Nübel, M. Ladwein, D. Antolovic, P. Klingbeil, D. Hildebrand, G. Moldenhauer, L. Langbein, W. W. Franke, J. Weitz and M. Zöller: Complex formation between EpCAM, claudin-7, and CD44 variant isoforms in tetraspanin-enriched microdomains promotes colorectal cancer progression. Mol Cancer Res in press
60. D. Herlyn and H. Koprowski: IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells. Proc Natl Acad Sci USA 79, 4761-4765 (1982)
61. H. F. Sears, B. Atkinson, J. Mattis, C. Ernst, D. Herlyn, Z. Steplewski, P. Hayry and H. Koprowski: Phase-I clinical trial of monoclonal antibody in treatment of gastrointestinal tumours. Lancet 1, 762-765 (1982) (Pubitemid 12192184)
62. M. Balzar, H. A. Bakker, I. H. Briaire-de-Bruijn, G. J. Fleuren, S. O. Warnaar and S. V. Litvinov: Cytoplasmic tail regulates the intercellular adhesion function of the epithelial cell adhesion molecule. Mol Cell Biol 18, 4833-4843 (1998) (Pubitemid 28343067)
63. G. Riethmüller, E. Schneider-Gadicke, G. Schlimok, W. Schmiegel, R. Raab, K. Höffken, R. Gruber, H. Pichlmaier, H. Hirche and R. Pichlmayr: Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group. Lancet 343, 1177-83 (1994) (Pubitemid 24147551)
64. D. G. Haller: Update of clinical trials with edrecolomab: a monoclonal antibody therapy for colorectal cancer. Semin Oncol 28, 25-30 (2001) (Pubitemid 32173101)
65. C. J. Punt, A. Nagy, J. Y. Douillard, A. Figer, T. Skovsgaard, J. Monson, C. Barone, G. Fountzilas, H. Riess, E. Moylan, D. Jones, J. Dethling. J. Colman, L. Coward and S. MacGregor: Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study. Lancet 360, 671-677 (2002) (Pubitemid 35232335)
66. W. Helfrich, B. J. Kroesen, R. C. Roovers, L. Westers, G. Molema, H. R. Hoogenboom and L. de Leij: Construction and characterization of a bispecific diabody for retargeting T cells to human carcinomas. Int J Cancer 76, 232-239 (1998)
67. P. H. Houba, E. Boven, I. H. van der Meulen-Muileman, R. G. Leenders, J. W. Scheeren, H. M. Pinedo and H. J. Haisma: Pronounced antitumor efficacy of doxorubicin when given as the prodrug DOX-GA3 in combination with a monoclonal antibody beta-glucuronidase conjugate. Int J Cancer 91, 550-554 (2001) (Pubitemid 32115112)
68. M. Andratschke, F. J. Gildehaus, V. Johannson, B. Schmitt, B Mack, G. Reisbach, S. Lang, H. Lindhofer, R. Zeidler, B. Wollenberg and C. W. Luebbers: Biodistribution and radioimmunotherapy of SCCHN in xenotransplantated SCID mice with a 131I-labelled anti-EpCAM monoclonal antibody. Anticancer Res 27, 431-436 (2007) (Pubitemid 46363364)
69. R. Riesenberg, A. Buchner, H. Pohla and H. Lindhofer: Lysis of prostate carcinoma cells by trifunctional bispecific antibodies (alpha EpCAM x alpha CD3). J Histochem Cytochem 49, 911-917 (2001) (Pubitemid 32565984)
70. R. Zeidler, J. Mysliwietz, M. Csanady, A. Walz, I. Ziegler, B. Schmitt, B. Wollenberg and H. Lindhofer: The Fc-region of a new class of intact bispecific antibody mediates activation of accessory cells and NK cells and induces direct phagocytosis of tumour cells. Br J Cancer 83, 261-266 (2000) (Pubitemid 30411727)
71. M. M. Heiss, M. A. Strohlein, M. Jager, R. Kimmig, A. Burges, A. Schoberth, K. W. Jauch, F. W. Schildberg and H. Lindhofer: Immunotherapy of malignant ascites with trifunctional antibodies. Int J Cancer 117, 435-443 (2005) (Pubitemid 41429567)
72. C. Schweizer, G. Strauss, M. Lindner, A. Marme, Y. M. Deo and G. Moldenhauer: Efficient carcinoma cell killing by activated polymorphonuclear neutrophils targeted with an Ep-CAMxCD64 (HEA125x197) bispecific antibody. Cancer Immunol Immunother 51, 621-629 (2002) (Pubitemid 35440515)
73. M. Sebastian, B. Passlick, H. Friccius-Quecke, M. Jager, H. Lindhofer, F. Kanniess, R. Wiewrodt, E. Thiel, R. Buhl and A. Schmittel: Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM x anti-CD3): a phase I study. Cancer Immunol Immunother (Epub ahead of print) 2007
74. I. Kirman and R. L. Whelan: Drug evaluation: adecatumumab, an engineered human anti-EpCAM antibody. Curr Opin Mol Ther 9, 190-196 (2007) (Pubitemid 46623952)
75. B. J. Stish, H. Chen, Y. Shu, A. Panoskaltsis-Mortari and D. A. Vallera: Increasing Anticarcinoma Activity of an Anti-erbB2 Recombinant Immunotoxin by the Addition of an Anti-EpCAM sFv. Clin Cancer Res 13, 3058-3067 (2007) (Pubitemid 46849583)
76. C. Boucheix and E. Rubinstein: Tetraspanins. Cell Mol Life Sci 58, 1189-2205 (2001)
77. M. Yunta and P. A. Lazo: Tetraspanin proteins as organisers of membrane microdomains and signalling complexes. Cell Signal 15, 559-564 (2003) (Pubitemid 36385161)
78. S. Levy and T. Shoham:. The tetraspanin web modulates immune-signalling complexes. Nat Rev Immunol 5, 136-148 (2005) (Pubitemid 40208903)
79. A. R. Kazarov, X. Yang, C. S. Stipp, B. Sehgal and M. E. Hemler: An extracellular site on tetraspanin CD151 determines alpha 3 and alpha 6 integrin-dependent cellular morphology. J Cell Biol 158, 1299-1309 (2002)
80. G. Z. Zhu, B. J. Miller, C. Boucheix, E. Rubinstein, C. C. Liu, R. O. Hynes, D. G. Myles and P. Primakoff: Residues SFQ (173-175) in the large extracellular loop of CD9 are required for gamete fusion. Development 129, 1995-2002 (2002) (Pubitemid 34874214)
81. C. S. Stipp, T. V. Kolesnikova and M. E. Hemler: Functional domains in tetraspanin proteins. Trends Biochem Sci 2003; 28: 106-112 (Pubitemid 36165140)
82. F. Berditchevski: Complexes of tetraspanins with integrins: more than meets the eye. J Cell Sci 114, 4143-4151 (2001) (Pubitemid 33138652)
83. S. Levy, S. C. Todd and H. T. Maecker: CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu Rev Immunol 16, 89-109 (1998) (Pubitemid 28183360)
84. N. Chattopadhyay, Z. Wang, L. K. Ashman, S. M. Brady-Kalnay and J. A. Kreidberg: alpha3beta1 integrin-CD151, a component of the cadherin-catenin complex, regulates PTPmu expression and cell-cell adhesion. J Cell Biol 163, 1351-1362 (2003) (Pubitemid 38032095)
85. J. Lämmerding, A. R. Kazarov, H. Huang, R. T. Lee and M. E. Hemler: Tetraspanin CD151 regulates alpha6beta1 integrin adhesion strengthening. Proc Natl Acad Sci USA 100, 7616-7621 (2003) (Pubitemid 36760018)
86. M. Herlevsen, D. S. Schmidt, K. Miyazaki and M., Zöller: The association of the tetraspanin D6.1A with the alpha6beta4 integrin supports cell motility and liver metastasis formation. J Cell Sci 116, 4373-4390 (2003) (Pubitemid 37369593)
87. X. Yang, C. Claas, S. K. Kraeft, L. B. Chen, Z. Wang, J. A. Kreidberg and M. E. Hemler: Palmitoylation of tetraspanin proteins: modulation of CD151 lateral interactions, subcellular distribution, and integrindependent cell morphology. Mol Biol Cell 13, 767-781 (2002) (Pubitemid 34250345)
88. F. Berditchevski, E. Odintsova, S. Sawada and E. Gilbert: Expression of the palmitoylation-deficient CD151 weakens the association of alpha 3 beta 1 integrin with the tetraspanin-enriched microdomains and affects integrindependent signaling. J Biol Chem 277, 36991-37000 (2002)
89. K. L. Clark, A. Oelke, M. E. Johnson, K. D. Eilert, P. C. Simpson and S. C. Todd: CD81 associates with 14-3-3 in a redox-regulated palmitoylation- dependent manner. J Biol Chem 279, 19401-1946 (2004)
90. C. Claas, J. Wahl, D. J. Orlicky, H. Karaduman, M. Schnölzer, T. Kempf and M. Zöller: The tetraspanin D6.1A and its molecular partners on rat carcinoma cells. Biochem J 389: 99-110 (2005) (Pubitemid 40978012)
91. A. Cherukuri, R. H. Carter, S. Brooks, W. Bornmann, R. Finn, C. S. Dowd and S. K. Pierce: B cell signaling is regulated by induced palmitoylation of CD81. J Biol Chem 279, 31973-31982 (2004) (Pubitemid 39037872)
92. C. Claas, C. S. Stipp and M. E. Hemler: Evaluation of prototype transmembrane 4 superfamily protein complexes and their relation to lipid rafts. J Biol Chem 276: 7974-7984 (2001)
93. S. I. Hakomori: Inaugural Article: The glycosynapse. Proc Natl Acad Sci USA 99: 225-232 (2002)
94. Y. Kawakami, K. Kawakami, W. F. Steelant, M. Ono, R. C. Baek, K. Handa, D. A. Withers and S. Hakomori: Tetraspanin CD9 is a "proteolipid, " and its interaction with alpha 3 integrin in microdomain is promoted by GM3 ganglioside, leading to inhibition of laminin-5-dependent cell motility. J Biol Chem 277, 34349-34358 (2002)
95. K. Simons and D. Toomre: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1, 31-39 (2000)
96. O. V. Kovalenko, X. Yang, T. V. Kolesnikova and M. E. Hemler: Evidence for specific tetraspanin homodimers: inhibition of palmitoylation makes cysteine residues available for cross-linking. Biochem J 377, 407-417 (2004) (Pubitemid 38142196)
97. I. De Curtis: Cell migration: GAPs between membrane traffic and the cytoskeleton. EMBO Rep 2, 277-281 (2001)
98. S. K. Hanks, L. Ryzhova, N. Y. Shin and J. Brabek: Focal adhesion kinase signaling activities and their implications in the control of cell survival and motility. Front Biosci 8, 982-996 (2003)
99. D. D. Schlaepfer and S. K. Mitra: Multiple connections link FAK to cell motility and invasion. Curr Opin Genet Dev 14, 92-101 (2004) (Pubitemid 38167483)
100. X. A. Zhang, A. L. Bontrager and M. E. Hemler: Transmembrane-4 superfamily proteins associate with activated protein kinase C (PKC) and link PKC to specific beta(1) integrins. J Biol Chem 276, 25005-25013 (2001)
101. C. Klein-Soyer, D. O. Azorsa, J. P. Cazenave and F. Lanza: CD9 participates in endothelial cell migration during in vitro wound repair. Arterioscler Thromb Vasc Biol 20, 360-369 (2000) (Pubitemid 30086091)
102. N. Longo, M. Yanez-Mo, M. Mittelbrunn, G. de la Rosa, M. L. Munoz, F. Sanchez-Madrid and P Sanchez-Mateos: Regulatory role of tetraspanin CD9 in tumorendothelial cell interaction during transendothelial invasion of melanoma cells. Blood 98, 3717-3726 (2001)
103. L. M. Lau, J. L. Wee, M. D. Wright, G. W. Moseley, P. M. Hogarth, L. K. Ashman and D. E. Jackson: The tetraspanin superfamily member CD151 regulates outsidein integrin alphaIIbbeta3 signaling and platelet function. Blood 104, 2368-2375 (2004) (Pubitemid 39331835)
104. M. D. Wright, S. M. Geary, S. Fitter, G. W. Moseley, L. M. Lau, K. C. Sheng, V. Apostolopoulos, E. G. Stanley, D. E. Jackson and L. K. Ashman: Characterization of mice lacking the tetraspanin superfamily member CD151. Mol Cell Biol 24, 5978-5988 (2004) (Pubitemid 38787980)
105. H. Kagawa, S. Nomura, T. Miyake T, Y. Miyazaki, H. Kido, M. Suzuki, M. Yanabu, S. Fukuhara, Y. Komiyama and H. Takahashi: Expression of prothrombinase activity and CD9 antigen on the surface of small vesicles from stimulated human endothelial cells. Thromb Res 80, 451-460 (1995)
106. P. Friedl, E. B. Bröcker: T cell migration in threedimensional extracellular matrix: guidance by polarity and sensations. Dev Immunol 7, 249-266 (2000)
107. A. M. Powelka, J. Sun, J. Li, M. Gao, L. M. Shaw, A. Sonnenberg and V. W. Hsu: Stimulation-dependent recycling of integrin beta1 regulated by ARF6 and Rab11. Traffic 5, 20-36 (2004) (Pubitemid 38159401)
108. M. A. Del Pozo: Integrin signaling and lipid rafts. Cell Cycle 3, 725-728 (2004) (Pubitemid 40187899)
109. T. Kobayashi, U. M. Vischer, C. Rosnoblet, C. Lebrand, M. Lindsay, R. G. Parton, E. K. Kruithof and J. Gruenberg: The tetraspanin CD63/lamp3 cycles between endocytic and secretory compartments in human endothelial cells. Mol Biol Cell 11, 1829-1843 (2000) (Pubitemid 30307916)
110. R. Wubbolts, R. S. Leckie, P. T. Veenhuizen, G. Schwarzmann, W. Mobius, J. Hoernschemeyer, J. W. Slot, H. J. Geuze and W. Stoorvogel: Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J Biol Chem 278, 10963-10972 (2003) (Pubitemid 36792644)
111. H. F. Heijnen, M. Van Lier, S. Waaijenborg, Y. Ohno-Iwashita, A. A. Waheed, M. Inomata, G. Gorter, W. Mobius, J. W. Akkerman and J. W. Slot: Concentration of rafts in platelet filopodia correlates with recruitment of c-Src and CD63 to these domains. J Thromb Haemost 1, 1161-1173 (2003)
112. F. Masciopinto, C. Giovani, S. Campagnoli, L. Galli-Stampino, P. Colombatto, M. Brunetto, T. S. Yen, M. Houghton, P. Pileri and S. Abrignani: Association of hepatitis C virus envelope proteins with exosomes. Eur J Immunol 34, 2834-2842 (2004) (Pubitemid 39430159)
113. K. Denzer, M. J. Kleijmeer, H. F. Heijnen, W. Stoorvogel and H. J. Geuze: Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci 113, 3365-3374 (2000)
114. J. S. Butler: The yin and yang of the exosome. Trends Cell Biol 12, 90-96 (2002) (Pubitemid 34146525)
115. B. Fevrier, and G. Raposo: Exosome secretion: the art of reutilizing nonrecycled proteins? Curr Opin Cell Biol 16, 415-421 (2004)
116. A. de Gassart, C. Geminard, D. Hoekstra and M. Vidal: Exosomes: endosomal-derived vesicles shipping extracellular messages. Traffic 5, 896-903 (2004)
117. F. Berditchevski: Complexes of tetraspanins with integrins: more than meets the eye. J Cell Sci 114, 4143-4151 (2001) (Pubitemid 33138652)
118. S. W. Feigelson, V. Grabovsky, R. Shamri, S. Levy and R. Alon: The CD81 tetraspanin facilitates instantaneous leukocyte VLA-4 adhesion strengthening to vascular cell adhesion molecule 1 (VCAM-1) under shear flow. J Biol Chem 278, 51203-51212 (2003) (Pubitemid 38020357)
119. A. Y. Hung and M. Sheng: PDZ domains: structural modules for protein complex assembly. J Biol Chem 277, 5699-5702 (2002) (Pubitemid 34968344)
120. X. A. Zhang, A. R. Kazarov, X. Yang, A. L. Bontrager, C. S. Stipp and M. E. Hemler: Function of the tetraspanin CD151-alpha6beta1 integrin complex during cellular morphogenesis. Mol Biol Cell 13, 1-11 (2002) (Pubitemid 34106054)
121. B. He, L. Liu, G. A. Cook, S. Grgurevich, L. K. Jennings and X. A. Zhang: Tetraspanin CD82 attenuates cellular morphogenesis through down-regulating integrin alpha6-mediated cell adhesion. J Biol Chem 280, 3346-3354 (2005) (Pubitemid 40223797)
122. S. Gesierich, I. Berezovskiy, E. Ryschich and M. Zöller: Systemic induction of the angiogenesis switch by the tetraspanin D6.1A/CO-029. Cancer Res 66, 7083-7094 (2006) (Pubitemid 44197685)
123. Y. Murayama, J. Miyagawa, K. Oritani, H. Yoshida, K. Yamamoto, O. Kishida, T. Miyazaki, S. Tsutsui, T. Kiyohara, Y. Miyazaki, S. Higashiyama, Y. Matsuzawa and Y. Shinomura: CD9-mediated activation of the p46 Shc isoform leads to apoptosis in cancer cells. J Cell Sci 117, 3379-3388 (2004) (Pubitemid 39139921)
124. I. Tachibana and M. E. Hemler: Role of transmembrane 4 superfamily (TM4SF) proteins CD9 and CD81 in muscle cell fusion and myotube maintenance. J Cell Biol 146, 893-904 (1999) (Pubitemid 29408913)
125. M Ono, K. Handa, D. A. Withers, and S. Hakomori: Motility inhibition and apoptosis are induced by metastasissuppressing gene product CD82 and its analogue CD9, with concurrent glycosylation. Cancer Res 59, 2335-2339 (1999) (Pubitemid 29242279)
126. A. Delaguillaumie, C. Lagaudriere-Gesbert, M. R. Popoff and H. Conjeaud: Rho GTPases link cytoskeletal rearrangements and activation processes induced via the tetraspanin CD82 in T lymphocytes. J Cell Sci 115, 433-443 (2002) (Pubitemid 34149680)
127. V. Carloni, A. Mazzocca and K. S. Ravichandran: Tetraspanin CD81 is linked to ERK/MAPKinase signaling by Shc in liver tumor cells. Oncogene 23, 1566-1374 (2004)
128. W. Shi, H. Fan, L. Shum and R. Derynck: The tetraspanin CD9 associates with transmembrane TGF-alpha and regulates TGF-alpha-induced EGF receptor activation and cell proliferation. J Cell Biol 148, 591-602 (2000)
129. Y. Yan, K. Shirakabe and Z. Werb: The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors. J Cell Biol 158, 221-226 (2002)
130. R. J. Bienstock and J. C. Barrett: KAI1, a prostate metastasis suppressor: prediction of solvated structure and interactions with binding partners; integrins, cadherins, and cell-surface receptor proteins. Mol Carcinog 32, 139-153 (2001) (Pubitemid 33055003)
131. N. Anzai, Y. Lee, B. S. Youn, S. Fukuda, Y. J. Kim, C. Mantel, M. Akashi and H. E. Broxmeyer: C-kit associated with the transmembrane 4 superfamily proteins constitutes a functionally distinct subunit in human hematopoietic progenitors. Blood 99, 4413-4421 (2002) (Pubitemid 34627209)
132. E. Odintsova, T. Sugiura and F. Berditchevski: Attenuation of EGF receptor signaling by a metastasis suppressor, the tetraspanin CD82/KAI-1. Curr Biol 10, 1009-1012 (2000)
133. C. Claas, S. Seiter, A. Claas, L. Savelyeva, M. Schwab and M. Zöller: Association between the rat homologue of CO-029, a metastasis-associated tetraspanin molecule and consumption coagulopathy. J Cell Biol 141, 267-280 (1998) (Pubitemid 28182657)
134. J. E. Testa, P. C. Brooks, J. M. Lin and J. P. Quigle: Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3/CD151) as an effector of human tumor cell migration and metastasis. Cancer Res 59, 3812-3820 (1999) (Pubitemid 29381891)
135. C. W. Rinker-Schaeffer, A. L. Hawkins, N. Ru, J. Dong, G. Stoica, C. A. Griffin, T. Ichikawa, J. C. Barrett and J. T. Isaacs: Differential suppression of mammary and prostate cancer metastasis by human chromosomes 17 and 11. Cancer Res 54, 6249-6256 (1994)
136. W. M. Liu and X. A. Zhang: KAI1/CD82, a tumor metastasis suppressor. Cancer Lett 240, 183-194 (2006) (Pubitemid 44093816)
137. D. P. Lombardi, J. Geradts, J. F. Foley, C. Chiao, P. W. Lamb and J. C. Barrett: Loss of KAI1 expression in the progression of colorectal cancer. Cancer Res 59, 5724-5731 (1999)
138. A. Takaoka, Y. Hinoda, S. Satoh, Y. Adachi, F. Itoh, M. Adachi and K. Imai: Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene. Oncogene 16, 1443-1453 (1998) (Pubitemid 28151851)
139. H. Friess, X. Z. Guo, A. A. Tempia-Caliera, A. Fukuda, M. E. Martignoni, A. Zimmermann, M. Korc and M. W. Buchler: Differential expression of metastasisassociated genes in papilla of vater and pancreatic cancer correlates with disease stage. J Clin Oncol 19, 2422-2432 (2001) (Pubitemid 32391213)
140. P. Jackson, A. Marreiros and P. J. Russell:. KAI1 tetraspanin and metastasis suppressor. Int J Biochem Cell Biol 37, 530-534 (2005) (Pubitemid 40022929)
141. J. Gu, M. Tamura, R. Pankov, E. H. Danen, T. Takino, K. Matsumoto and K. M. Yamada: Shc and FAK differentially regulate cell motility and directionality modulated by PTEN. J Cell Biol 146, 389-403 (1999) (Pubitemid 29369775)
142. R. L. Klemke, J. Leng, R. Molander, P. C. Brooks, K. Vuori and D. A. Cheresh: CAS/Crk coupling serves as a "molecular switch" for induction of cell migration. J Cell Biol 140, 961-972 (1998) (Pubitemid 28141232)
143. T. V. Kolesnikova, C. S. Stipp, R. M. Rao, W. S. Lane, F. W. Luscinskas and M. E. Hemler: EWI-2 modulates lymphocyte integrin alpha4beta1 functions.
144. X. A. Zhang, B. He, B. Zhou and L. Liu: Requirement of the p130CAS-Crk coupling for metastasis suppressor KAI1/CD82-mediated inhibition of cell migration. J Biol Chem 278, 27319-27328 (2003) (Pubitemid 36876890)
145. S. Charrin, S. Manie, C. Thiele, M. Billard, D. Gerlier, C. Boucheix and E. Rubinstein: A physical and functional link between cholesterol and tetraspanins. Eur J Immunol 33, 2479-2489 (2003) (Pubitemid 37138980)
146. E. Odintsova, J. Voortman, E. Gilbert and F. Berditchevski: Tetraspanin CD82 regulates compartmentalisation and ligand-induced dimerization of EGFR. J Cell Sci 116, 4557-4566 (2003) (Pubitemid 37461610)
147. S. C. Sridhar and C. K. Miranti: Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrindependent crosstalk with c-Met receptor and Src kinases. Oncogene 25, 2367-2378 (2006)
148. J. H. Lee, S. R. Park, K. O. Chay, Y. W. Seo, H. Kook, K. Y. Ahn, Y. J. Kim and K. K. Kim: KAI1 COOHterminal interacting tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumor metastasis suppressor, and enhances metastasis of cancer. Cancer Res 64, 4235-4243 (2004) (Pubitemid 38802428)
149. R. Bass, F. Werner, E. Odintsova, T. Sugiura, F. Berditchevski and V. Ellis: Regulation of urokinase receptor proteolytic function by the tetraspanin CD82. J Biol Chem 280, 14811-14818 (2005) (Pubitemid 40562830)
150. H. Hashida, A. Takabayashi, T. Tokuhara, N. Hattori, T. Taki, H. Hasegawa, S. Satoh, N. Kobayashi, Y. Yamaoka and M. Miyake: Clinical significance of transmembrane 4 superfamily in colon cancer. Br J Cancer 89, 158-167 (2003) (Pubitemid 36897952)
151. T. Tokuhara, H. Hasegawa, N. Hattori, H. Ishida, T. Taki, S. Tachibana, S. Sasaki and M. Miyake: Clinical significance of CD151 gene expression in nonsmall cell lung cancer. Clin Cancer Res 7, 4109-4114 (2001) (Pubitemid 34044635)
152. S. Gesierich, C. Paret, D. Hildebrand, J. Weitz, K. Zgraggen, F. H. Schmitz-Winnenthal, V. Horejsi, O. Yoshie, D. Herlyn, L. K. Ashman and M. Zöller: Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: impact on cell motility. Clin Cancer Res 11, 2840-2852 (2005) (Pubitemid 40525182)
153. J. Ang, M. Lijovic, L. K. Ashman, K. Kan and A. G. Frauman: CD151 protein expression predicts the clinical outcome of low-grade primary prostate cancer better than histologic grading: a new prognostic indicator? Cancer Epidemiol Biomarkers Prev 13, 1717-1721 (2004) (Pubitemid 39482947)
154. M. Kohno, H. Hasegawa, M. Miyake, T. Yamamoto and S. Fujita. CD151 enhances cell motility and metastasis of cancer cells in the presence of focal adhesion kinase. Int J Cancer 97, 336-343 (2002) (Pubitemid 34049024)
155. R. Lan, Z. Liu, Y. Song and X. Zhang: Effects of rAAVCD151 and rAAV-antiCD151 on the migration of human tongue squamous carcinoma cell line Tca8113. J Huazhong Univ Sci Technolog Med Sci 24, 556-559 (2004) (Pubitemid 41564184)
156. M. Shigeta, N. Sanzen, M. Ozawa, J. Gu, H. Hasegawa and K. Sekiguchi: CD151 regulates epithelial cell-cell adhesion through PKC-and Cdc42-dependent actin cytoskeletal reorganization. J Cell Biol 163, 165-176 (2003) (Pubitemid 37271443)
157. T. Shiomi, I. Inoki, F. Kataoka, T. Ohtsuka, G. Hashimoto, R. Nemori and Y. Okada: Pericellular activation of proMMP-7 (promatrilysin-1) through interaction with CD151. Lab Invest 85, 1489-1506 (2005) (Pubitemid 41662334)
158. C. Boucheix, G. H. Duc, C. Jasmin and E. Rubinstein: Tetraspanins and malignancy. Expert Rev Mol Med 2001, 1-17 (2001)
159. B. A. Sela, Z. Steplewski and H. Koprowski: Colon carcinoma-associated glycoproteins recognized by monoclonal antibodies CO-029 and GA22-2. Hybridoma 8:481-491 (1989) (Pubitemid 19196944)
160. S. Huerta, D. M. Harris, A. Jazirehi, B. Bonavida, D. Elashoff, E. H. Livingston and D. Heber: Gene expression profile of metastatic colon cancer cells resistant to cisplatin-induced apoptosis. Int J Oncol 22, 663-670 (2003)
161. K. Kanetaka, M. Sakamoto, Y. Yamamoto, M. Takamura, T. Kanematsu and S. Hirohashi: Overexpression of tetraspanin CO-029 in hepatocellular carcinoma. J Hepatol 35, 637-642 (2001) (Pubitemid 33078274)
162. R. L. Bick: Platelet function defects: a clinical review. Semin Thromb Hemost 18, 353-372 (1992)
163. K. Kanetaka, M. Sakamoto, Y. Yamamoto, M. Takamura, T. Kanematsu and S. Hirohashi: Possible involvement of tetraspanin CO-029 in hematogenous intrahepatic metastasis of liver cancer cells. J Gastroenterol Hepatol 18, 1309-1314 (2003) (Pubitemid 37464007)
164. T. A. Martin and W.G. Jiang: Tight junctions and their role in cancer metastasis. Histol Histopathol 16, 1183-1195 (2001) (Pubitemid 32994462)
165. E. E. Schneeberger and R. D. Lynch: The tight junction: a multifunctional complex. Am. J Physiol Cell Physiol 286, 1213-1228 (2004)
166. S. Tsukita and M. Furuse: Occludin and claudins in tight-junction strands: leading or supporting players? Trends Cell Biol 9, 268-273 (1999) (Pubitemid 29305516)
167. M. S. Balda and K. Matter: Tight junctions. J Cell Sci 111, 541-547 (1998) (Pubitemid 28142359)
168. B. R. Stevenson and B. H. Keon: The tight junction: morphology to molecules. Annu Rev Cell Dev Biol 14, 89-109 (1998) (Pubitemid 29001450)
169. J. Ikenouchi, M. Furuse, K. Furuse, H. Sasaki, S. Tsukita and S. Tsukita: Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells. J Cell Biol 171, 939-945 (2005) (Pubitemid 41815826)
170. K. M. McCarthy, I. B. Skare, M. C. Stankewich, M. Furuse, S. Tsukita, R. A. Rogers, R. D. Lynch and E. E. Schneeberger: Occludin is a functional component of the tight junction. J Cell Sci 109, 2287-2298 (1996) (Pubitemid 26325491)
171. G. Bazzoni: The JAM family of junctional adhesion molecules. Curr Opin Cell Biol 15, 525-530 (2003) (Pubitemid 37176960)
172. L. Gonzalez-Mariscal, A. Betanzos, P. Nava and B. E. Jaramillo: Tight junction proteins. Prog Biophys Mol Biol 81, 1-44 (2003) (Pubitemid 35436609)
173. K. Morita, M. Furuse, K. Fujimoto and S. Tsukita: Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci USA 96, 511-516 (1999) (Pubitemid 29061239)
174. O. R. Colegio, C. M. Van Itallie, H. J. McCrea, C. Rahner and J. M. Anderson: Claudins create chargeselective channels in the paracellular pathway between epithelial cells. Am J Physiol Cell Physiol 283, 142-147 (2002)
175. K. Fujita, J. Katahira, Y. Horiguchi, N. Sonoda, M. Furuse and S. Tsukita: Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein. FEBS Lett 476, 258-261 (2000) (Pubitemid 30410828)
176. M. Itoh, M. Furuse, K. Morita, K. Kubota, M. Saitou and S. Tsukita: Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol 147, 1351-1363 (1999) (Pubitemid 30012818)
177. M. Itoh, H. Sasaki, M. Furuse, H. Ozaki, T. Kita and S. Tsukita: Junctional adhesion molecule (JAM) binds to PAR-3: a possible mechanism for the recruitment of PAR-3 to tight junctions. J Cell Biol 154, 491-497 (2001) (Pubitemid 34286156)
178. L. L. Mitic, C. M. Van Itallie and J. M. Anderson: Molecular physiology and pathophysiology of tight junctions I. Tight junction structure and function: lessons from mutant animals and proteins. Am J Physiol Gastrointest Liver Physiol 279, 250-254 (2000)
179. S. Tsukita and M. Furuse and M. Itoh: Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2, 285-293 (2001) (Pubitemid 33676971)
180. C. Yeaman, K. K. Grindstaff, M. D. Hansen and W. J. Nelson: Cell polarity: Versatile scaffolds keep things in place. Curr Biol 9, 515-517 (1999)
181. M. H. Roh and B. Margolis: Composition and function of PDZ protein complexes during cell polarization. Am J Physiol Renal Physiol 285, 377-387 (2003)
182. W. J. Nelson: Adaptation of core mechanisms to generate cell polarity. Nature 422, 766-774 (2003) (Pubitemid 36514120)
183. A. Suzuki, C. Ishiyama, K. Hashiba, M. Shimizu, K. Ebnet and S. Ohno: aPKC kinase activity is required for the asymmetric differentiation of the premature junctional complex during epithelial cell polarization. J Cell Sci 115, 3565-3573 (2002)
184. M. Behr, D. Riedel and R. Schuh: The claudin-like megatrachea is essential in septate junctions for the epithelial barrier function in Drosophila. Dev Cell 5, 611-620 (2003) (Pubitemid 37243049)
185. J. S. Simske, M. Koppen, P. Sims, J. Hodgkin, A. Yonkof and J. Hardin: The cell junction protein VAB-9 regulates adhesion and epidermal morphology in C. elegans. Nat Cell Biol 5, 619-625 (2003) (Pubitemid 36818083)
186. J. M. Anderson, C. M. Van Itallie and A. S. Fanning: Setting up a selective barrier at the apical junction complex. Curr Opin Cell Biol 16, 140-145 (2004) (Pubitemid 38757290)
187. A. S. Fanning, T. Y. Ma and J. M. Anderson: Isolation and functional characterization of the actin binding region in the tight junction protein ZO-1. FASEB J 16, 1835-1837 (2002)
188. C. M. Van Itallie, T. M. Gambling, J. L. Carson and J. M. Anderson: Palmitoylation of claudins is required for efficient tight-junction localization. J Cell Sci 118, 1427-1436 (2005) (Pubitemid 40585123)
189. G. I. Miura and J. E. Treisman: Lipid modification of secreted signaling proteins. Cell Cycle 5, 1184-1188 (2006) (Pubitemid 43845378)
190. M. E. Linder and R. J. Deschenes: Palmitoylation: policing protein stability and traffic. Nat Rev Mol Cell Biol 8, 74-84 (2007) (Pubitemid 46012016)
191. M. Edidin: Lipids on the frontier: a century of cellmembrane bilayers. Nat Rev Mol Cell Biol 4, 414-418 (2003) (Pubitemid 36565573)
192. A. Nusrat, C. A. Parkos, P. Verkade, C. S. Foley, T. W. Liang, W. Innis-Whitehouse, K. K. Eastburn and J. L. Madara: Tight junctions are membrane microdomains. J Cell Sci 113, 1771-1781 (2000) (Pubitemid 30333126)
193. L. L. Mitic, V. M. Unger and J. M. Anderson: Expression, solubilization, and biochemical characterization of the tight junction transmembrane protein claudin-4. Protein Sci 12, 218-227 (2003) (Pubitemid 36120334)
194. H. Sasaki, C. Matsui, K. Furuse, Y. Mimori-Kiyosue, M. Furuse and S. Tsukita: Dynamic behavior of paired claudin strands within apposing plasma membranes. Proc Natl Acad Sci U S A 100, 3971-3976 (2003) (Pubitemid 36418141)
195. M. Matsuda, A. Kubo, M. Furuse and S. Tsukita: A peculiar internalization of claudins, tight junction-specific adhesion molecules, during the intercellular movement of epithelial cells. J Cell Sci 117, 1247-1257 (2004) (Pubitemid 38456105)
196. A. I. Ivanov, A. Nusrat, C. A. Parkos: Endocytosis of epithelial apical junctional proteins by a clathrin-mediated pathway into a unique storage compartment. Mol Biol Cell 15, 176-188 (2004) (Pubitemid 38044954)
197. L. Shen and J. R. Turner: Actin depolymerization disrupts tight junctions via caveolae-mediated endocytosis. Mol Biol Cell 16, 3919-3936 (2005) (Pubitemid 41262867)
198. A. I. Ivanov, A: Nusrat and C. A. Parkos: The epithelium in inflammatory bowel disease: potential role of endocytosis of junctional proteins in barrier disruption. Novartis Found Symp 263, 115-124 (2004)
199. M. Utech, A. I. Ivanov, S. N. Samarin, M. Bruewer, J. R. Turner, R. J. Mrsny, C. A. Parkos and A. Nusrat: Mechanism of IFN-gamma-induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane. Mol Biol Cell 16, 5040-5052 (2005) (Pubitemid 41416480)
200. T. D'Souza, R. Agarwal and P. J. Morin: Phosphorylation of claudin-3 at threonine 192 by cAMP-dependent protein kinase regulates tight junction barrier function in ovarian cancer cells. J Biol Chem 280, 26233-26240 (2005) (Pubitemid 41022220)
201. V. Nunbhakdi-Craig, T. Machleidt, E. Ogris, D. Bellotto, C. L. White 3rd and E. Sontag: Protein phosphatase 2A associates with and regulates atypical PKC and the epithelial tight junction complex. J Cell Biol 158, 967-978 (2002) (Pubitemid 35001086)
202. M Tanaka, R. Kamata and R Sakai: Phosphorylation of ephrin-B1 via the interaction with claudin following cellcell contact formation. EMBO J 24, 3700-3711 (2005) (Pubitemid 41581687)
203. E. B. Pasquale: Eph receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol 6, 462-475 (2005) (Pubitemid 40780558)
204. J. Ikenouchi, M. Matsuda, M. Furuse and S. Tsukita: Regulation of tight junctions during the epitheliummesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail. J Cell Sci 116, 1959-1967 (2003) (Pubitemid 36622294)
205. F. Carrozzino, P. Soulie, D. Huber, N. Mensi, L. Orci, A. Cano, E. Feraille and R. Montesano: Inducible expression of Snail selectively increases paracellular ion permeability and differentially modulates tight junction proteins. Am J Physiol Cell Physiol 289, 1002-1014 (2005)
206. R. Okamoto, K. Irie, A. Yamada, T. Katata, A. Fukuhara and Y. Takai: Recruitment of E-cadherin associated with alpha-and beta-catenins and p120ctn to the nectin-based cell-cell adhesion sites by the action of 12- Otetradecanoylphorbol-13-acetate in MDCK cells. Genes Cells 10, 435-445 (2005) (Pubitemid 40590361)
207. T. Ohkubo and M. Ozawa: The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation. J Cell Sci 117, 1675-1685 (2004) (Pubitemid 38559300)
208. F. Escaffit, F. Boudreau and J. F. Beaulieu: Differential expression of claudin-2 along the human intestine: Implication of GATA-4 in the maintenance of claudin-2 in differentiating cells. J Cell Physiol 203, 15-26 (2005) (Pubitemid 40328168)
209. S. Satohisa, H. Chiba, M. Osanai, S. Ohno, T. Kojima, T. Saito and N. Sawada: Behavior of tight-junction, adherens-junction and cell polarity proteins during HNF-4alpha-induced epithelial polarization. Exp Cell Res 310, 66-78 (2005) (Pubitemid 41393688)
210. J. H. Lipschutz, S. Li, A. Arisco and D. F. Balkovetz: Extracellular signal-regulated kinases 1/2 control claudin-2 expression in Madin-Darby canine kidney strain I and II cells. J Biol Chem 280, 3780-3788 (2005) (Pubitemid 40223847)
211. H. Schmitz, C. Barmeyer, A. H. Gitter, F. Wullstein, C. J. Bentzel, M. Fromm, E. O. Riecken and J. D. Schulzke: Epithelial barrier and transport function of the colon in ulcerative colitis. Ann N Y Acad Sci 915, 312-326 (2000) (Pubitemid 32059397)
212. S. V. Walsh, A. M. Hopkins and A. Nusrat: Modulation of tight junction structure and function by cytokines. Adv Drug Deliv Rev 41, 303-313 (2000) (Pubitemid 30347380)
213. T. Kinugasa, T. Sakaguchi, X. Gu and H. C. Reinecker: Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology 118, 1001-1011 (2000) (Pubitemid 30346975)
214. A. B. Singh, T. Tsukada, R. Zent and R. C. Harris: Membrane-associated HB-EGF modulates HGF-induced cellular responses in MDCK cells. J Cell Sci 117, 1365-1379 (2004) (Pubitemid 38559814)
215. T. Yamamoto, T. Kojima, M. Murata, K. Takano, M. Go, H. Chiba and N. Sawada: IL-1beta regulates expression of Cx32, occludin, and claudin-2 of rat hepatocytes via distinct signal transduction pathways. Exp Cell Res 299, 427-441 (2004) (Pubitemid 39179809)
216. X. Han, M. P. Fink and R. L. Delude: Proinflammatory cytokines cause NO*-dependent and -independent changes in expression and localization of tight junction proteins in intestinal epithelial cells. Shock 19, 229-237 (2003)
217. M. Imamura, T. Kojima, M. Lan, S. Son, M. Murata, M Osanai, H. Chiba, K. Hirata and N. Sawada: Oncostatin M induces upregulation of claudin-2 in rodent hepatocytes coinciding with changes in morphology and function of tight junctions. Exp Cell Res 313, 1951-6192 (2007)
218. M. Lan, T. Kojima, M. Osanai, H. Chiba and N. Sawada: Oncogenic Raf-1 regulates epithelial to mesenchymal transition via distinct signal transduction pathways in an immortalized mouse hepatic cell line. Carcinogenesis 25, 2385-2395 (2004) (Pubitemid 39625179)
219. J. M.Mullin, J. M. Leatherman, M. C. Valenzano, E. R. Huerta, J. Verrechio, D. M. Smith, K. Snetselaar, M. Liu, M. K. Francis and C. Sell: Ras mutation impairs epithelial barrier function to a wide range of nonelectrolytes. Mol Biol Cell 16, 5538-5550 (2005) (Pubitemid 41752205)
220. M. Murata, T. Kojima, T. Yamamoto, M. Go, K. Takano, M. Osanai, H. Chiba and N. Sawada: Downregulation of survival signaling through MAPK and Akt in occludin-deficient mouse hepatocytes in vitro. Exp Cell Res 310, 140-151 (2005) (Pubitemid 41393695)
221. M D. Alexandre, Q. Lu and Y. H. Chen: Overexpression of claudin-7 decreases the paracellular Clconductance and increases the paracellular Na+ conductance in LLC-PK1 cells. J Cell Sci 118, 2683-2693 (2005) (Pubitemid 40932893)
222. M. D. Alexandre, B. G. Jeansonne, R. H. Renegar, R. Tatum and Y. H. Chen: The first extracellular domain of claudin-7 affects paracellular Cl-permeability. Biochem Biophys Res Commun 357, 87-91 (2007) (Pubitemid 46574503)
223. M. Go, T. Kojima, K. Takano, M. Murata, S. Ichimiya, H. Tsubota, T. Himi and N. Sawada: Expression and function of tight junctions in the crypt epithelium of human palatine tonsils. J Histochem Cytochem 52, 1627-1638 (2004) (Pubitemid 39603261)
224. L. Gonzalez-Mariscal, C. Namorado Mdel, D. Martin, G. Sierra and J. L. Reyes: The tight junction proteins claudin-7 and -8 display a different subcellular localization at Henle's loops and collecting ducts of rabbit kidney. Nephrol Dial Transplant 21, 2391-2398 (2006) (Pubitemid 44644509)
225. H. Fujita, H. Chiba, H. Yokozaki, N. Sakai, K. Sugimoto, T. Wada, T. Kojima, T. Yamashita and N. Sawada: Differential expression and subcellular localization of claudin-7, -8, -12, -13, and -15 along the mouse intestine. J Histochem Cytochem 54, 933-944 (2006) (Pubitemid 44106871)
226. V. G. Brunton, I. R. MacPherson and M. C. Frame: Cell adhesion receptors, tyrosine kinases and actin modulators: a complex three-way circuitry. Biochim Biophys Acta 1692, 121-144 (2004) (Pubitemid 38891770)
227. A. P. Soler, R. D. Miller, K. V. Laughlin, N. Z. Carp, D. M. Klurfeld and J. M. Mullin: Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis 20, 1425-1431 (1999) (Pubitemid 29385425)
228. J. M. Mullin: Potential interplay between luminal growth factors and increased tight junction permeability in epithelial carcinogenesis. J Exp Zool 279, 484-489 (1997) (Pubitemid 27523409)
229. T. A. Martin and W. G. Jiang: Tight junctions and their role in cancer metastasis. Histol Histopathol 16, 1183-1195 (2001) (Pubitemid 32994462)
230. F. Kramer, K. White, M. Kubbies, K. Swisshelm and B. H. Weber: Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer. Hum Genet 107, 249-256 (2000)
231. A. M. Tokes, J. Kulka, S. Paku, A. Szik, C. Paska, P. K. Novak, L. Szilak, A. Kiss, K. Bogi and Z. Schaff: Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res 7, 296-305 (2005)
232. M. B. Resnick, T. Konkin, J. Routhier, E. Sabo and V. E. Pricolo: Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study. Mod Pathol 18, 511-518 (2005) (Pubitemid 40478114)
233. K. Swisshelm, R. Macek and M. Kubbies: Role of claudins in tumorigenesis. Adv Drug Deliv Rev 57, 919-928 (2005) (Pubitemid 40488110)
234. G. M. Sheehan, B. V. Kallakury, C. E. Sheehan, H. A. Fisher, R. P. Kaufman Jr and J. S. Ross: Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas. Hum Pathol 38, 564-569 (2007) (Pubitemid 46399893)
235. S. L. Kominsky, P. Argani, D. Korz, E. Evron, V. Raman, E. Garrett, A. Rein, G. Sauter, O. P. Kallioniemi and S. Sukumar: Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 22, 2021-2033 (2003) (Pubitemid 36523639)
236. T. Sauer, M. K. Pedersen, K. Ebeltoft and O. Naess: Reduced expression of Claudin-7 in fine needle aspirates from breast carcinomas correlate with grading and metastatic disease. Cytopathology 16, 193-198 (2005) (Pubitemid 41112978)
237. D. Park, R. Karesen, U. Axcrona, T. Noren and T Sauer: Expression pattern of adhesion molecules (Ecadherin, alpha-, beta-, gamma-catenin and claudin-7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasis. APMIS 115, 52-65 (2007) (Pubitemid 46066574)
238. B. Blackman, T. Russell, S. K. Nordeen, D. Medina and M. C. Neville: Claudin 7 expression and localization in the normal murine mammary gland and murine mammary tumors. Breast Cancer Res 7, 248-255 (2005)
239. A. E. Al Moustafa, M. A. Alaoui-Jamali, G. Batist, M. Hernandez-Perez, C. Serruya, L. Alpert, M. J. Black, R. Sladek and W. D. Foulkes: Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene 21, 2634-2640 (2002) (Pubitemid 34478321)
240. M. Lioni, P. Brafford, C. Andl, A. Rustgi, W. El-Deiry, M. Herlyn and K. S. Smalley: Dysregulation of claudin-7 leads to loss of E-cadherin expression and the increased invasion of esophageal squamous cell carcinoma cells. Am J Pathol 170, 709-721 (2007) (Pubitemid 47342407)
241. Y. Usami, H. Chiba, F. Nakayama, J. Ueda, Y. Matsuda, N. Sawada, T. Komori, A. Ito and H. Yokozaki: Reduced expression of claudin-7 correlates with invasion and metastasis in squamous cell carcinoma of the esophagus. Hum Pathol 37, 569-577 (2006)
242. J. W. Lee, S. J. Lee, J. Seo, S. Y. Song, G. Ahn, C. S. Park, J. H. Lee, B. G. Kim and D. S. Bae: Increased expressions of claudin-1 and claudin-7 during the progression of cervical neoplasia. Gynecol Oncol 97, 53-59 (2005) (Pubitemid 40403674)
243. E. Montgomery, A. J. Mamelak, M. Gibson, A. Maitra, S. Sheikh, S. S. Amr, S. Yang, M. Brock, A. Forastiere, S. Zhang, K. M. Murphy and K. D. Berg KD. Overexpression of claudin proteins in esophageal adenocarcinoma and its precursor lesions. Appl Immunohistochem Mol Morphol 14, 24-30 (2006)
244. C. D. Hough, C. A. Sherman-Baust, E. S. Pizer, F. J. Montz, D. D. Im, N. B. Rosenshein, K. R. Cho, G. J. Riggins and P. J. Morin: Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res 60, 6281-6287 (2000)
245. L. B. Rangel, R. Agarwal, T. D'Souza, E. S. Pizer, P. L. Alo, W. D. Lancaster, L. Gregoire, D. R. Schwartz, K. R. Cho and P. J. Morin: Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin Cancer Res 9, 2567-2575 (2003) (Pubitemid 36842098)
246. K. Hibbs, K. M. Skubitz, S. E. Pambuccian, R. C. Casey, K. M. Burleson, T. R. Oegema Jr, J. J. Thiele, S. M. Grindle, R. L. Bliss and A. P. Skubitz: Differential gene expression in ovarian carcinoma: identification of potential biomarkers. Am J Pathol 165, 397-414 (2004) (Pubitemid 38971371)
247. K. H. Lu, A. P. Patterson, L. Wang, R. T. Marquez, E. N. Atkinson, K. A. Baggerly, L. R. Ramoth, D. G. Rosen, J. Liu, I. Hellstrom, D. Smith, L. Hartmann, D. Fishman, A. Berchuck, R. Schmandt, R. Whitaker, D. M. Gershenson, G. B. Mills, and R. C. Bast Jr.: Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin Cancer Res 10, 3291-3300 (2004) (Pubitemid 38685433)
248. A. D. Santin, F. Zhan, S. Bellone, M. Palmieri, S. Cane, E. Bignotti, S. Anfossi, M. Gokden, D. Dunn, J. J. Roman, T. J. O'Brien, E. Tian, M. J. Cannon, J. Shaughnessy Jr, and S. Pecorelli: Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy. Int J Cancer 112, 14-25 (2004) (Pubitemid 39249487)
249. S. L. Kominsky, M. Vali, D. Korz, T. G. Gabig, S. A. Weitzman, P. Argani and S. Sukumar: Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4. Am J Pathol 164, 1627-1633 (2004) (Pubitemid 38529765)
250. H. Long, C. D. Crean, W. H. Lee, O. W. Cummings and T. G. Gabig: Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. Cancer Res 61, 7878-7881 (2001) (Pubitemid 33049378)
251. T. M. Gress, F. Muller-Pillasch, M. Geng, F. Zimmerhackl, G. Zehetner, H. Friess, M. Buchler, G. Adler and H. Lehrach: A pancreatic cancer-specific expression profile. Oncogene 13, 1819-1830 (1996) (Pubitemid 26377516)
252. P. Michl, M. Buchholz, M. Rölke, S. Kunsch, M. Löhr, B. McClane, S. Tsukita, G. Leder, G. Adler and T. M. Gress: Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology 121, 678-684 (2001) (Pubitemid 32822583)
253. L. S. Nichols, R. Ashfaq and C. A. Iacobuzio-Donahue: Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target. Am J Clin Pathol 121, 226-230 (2004) (Pubitemid 38140127)
254. N. Sato, N. Fukushima, A. Maitra, C. A. Iacobuzio-Donahue, N. T. van Heek, J. L. Cameron, C. J. Yeo, R. H. Hruban and M. Goggins: Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas. Am J Pathol 164, 903-914 (2004) (Pubitemid 38235472)
255. B. Terris, E. Blaveri, T. Crnogorac-Jurcevic, M. Jones, E. Missiaglia, P. Ruszniewski, A. Sauvanet and N. R. Lemoine: Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas. Am J Pathol 160, 1745-1754 (2002) (Pubitemid 34525654)
256. Y. D. Choi, K. S. Kim, S. Ryu, Y. Park, N. H. Cho, S. H. Rha, J. J. Jang, J. Y. Ro, S. W. Juhng and C. Choi: Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma. J Korean Med Sci 22, 305-310 (2007)
257. R. Guenther, V. Krenn, L. Morawietz, A. Dankof, I. Melcher, K. D. Schaser, H. U. Kasper, R. J. Kuban, U. Ungethum and C. Sers: Giant cell tumors of the bone: molecular profiling and expression analysis of Ephrin A1 receptor, Claudin 7, CD52, FGFR3 and AMFR. Pathol Res Pract 201, 649-663 (2005) (Pubitemid 41487594)
258. J. Borlak, T. Meier, R. Halter, R. Spanel and K. Spanel-Borowski: Epidermal growth factor-induced hepatocellular carcinoma: gene expression profiles in precursor lesions, early stage and solitary tumours. Oncogene 24, 1809-1819 (2005) (Pubitemid 40462784)
259. A. H. Johnson, H. F. Frierson, A. Zaika, S. M. Powell, J. Roche, S. Crowe, C. A. Moskaluk and W. El-Rifai: Expression of tight-junction protein claudin-7 is an early event in gastric tumorigenesis. Am J Pathol 167, 577-584 (2005) (Pubitemid 43026111)
260. J. Y. Zheng, D. Yu, M. Foroohar, E. Ko, J. Chan, N. Kim, R. Chiu and S. Pang: Regulation of the expression of the prostate-specific antigen by claudin-7. J Membr Biol 194, 187-197 (2003) (Pubitemid 37013811)
261. M. Fujibe, H. Chiba, T. Kojima, T. Soma, T. Wada, T. Yamashita and N. Sawada: Thr203 of claudin-1, a putative phosphorylation site for MAP kinase, is required to promote the barrier function of tight junctions. Exp Cell Res 295, 36-47 (2004) (Pubitemid 38407343)
262. T. Ishizaki, H. Chiba, T. Kojima, M. Fujibe, T. Soma, H. Miyajima, K. Nagasawa, I. Wada and N. Sawada: Cyclic AMP induces phosphorylation of claudin-5 immunoprecipitates and expression of claudin-5 gene in blood-brain-barrier endothelial cells via protein kinase Adependent and -independent pathways. Exp Cell Res 290, 275-288 (2003) (Pubitemid 37272172)
263. T. Soma, H. Chiba, Y. Kato-Mori, T. Wada, T. Yamashita, T. Kojima and N. Sawada: Thr(207) of claudin-5 is involved in size-selective loosening of the endothelial barrier by cyclic AMP. Exp Cell Res 300, 202-212 (2004) (Pubitemid 39286229)
264. K. Yamauchi, T. Rai, K. Kobayashi, E. Sohara, T. Suzuki, T. Itoh, S. Suda, A. Hayama, S. Sasaki and S. Uchida: Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins. Proc Natl Acad Sci USA 101, 4690-4694 (2004) (Pubitemid 38437472)
265. R. Agarwal, T. D'Souza and P. J. Morin: Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res 65, 7378-7385 (2005) (Pubitemid 41161271)
266. F. Le Naour, M. Andre, C. Greco, M. Billard, B. Sordat, J. F. Emile, F. Lanza, C. Boucheix and E. Rubinstein: Profiling of the tetraspanin web of human colon cancer cells. Mol Cell Proteomics 5, 845-857 (2006) (Pubitemid 43792794)
267. S. Charrin, F. Le Naour, V. Labas, M. Billard, J. P. Le Caer, J. F. Emile, M. A. Petit, C. Boucheix and E. Rubinstein: EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cells. Biochem J 373, 409-421 (2003) (Pubitemid 36897844)
268. J. Würfel, M. Rösel, S. Seiter, C. Claas, M. Herlevsen, R. Weth and M. Zöller: Metastasis-association of the rat ortholog of the human epithelial glycoprotein antigen EGP314. Oncogene 18, 2323-2334 (1999) (Pubitemid 29192709)